rs13336129

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002968.3(SALL1):​c.475A>G​(p.Ser159Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0943 in 1,243,758 control chromosomes in the GnomAD database, including 3,526 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S159R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.066 ( 382 hom., cov: 31)
Exomes 𝑓: 0.098 ( 3144 hom. )

Consequence

SALL1
NM_002968.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0900

Publications

17 publications found
Variant links:
Genes affected
SALL1 (HGNC:10524): (spalt like transcription factor 1) The protein encoded by this gene is a zinc finger transcriptional repressor and may be part of the NuRD histone deacetylase complex (HDAC). Defects in this gene are a cause of Townes-Brocks syndrome (TBS) as well as bronchio-oto-renal syndrome (BOR). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SALL1 Gene-Disease associations (from GenCC):
  • Townes-Brocks syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Townes-Brocks syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002341956).
BP6
Variant 16-51141747-T-C is Benign according to our data. Variant chr16-51141747-T-C is described in ClinVar as Benign. ClinVar VariationId is 258875.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0823 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SALL1NM_002968.3 linkc.475A>G p.Ser159Gly missense_variant Exon 2 of 3 ENST00000251020.9 NP_002959.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SALL1ENST00000251020.9 linkc.475A>G p.Ser159Gly missense_variant Exon 2 of 3 1 NM_002968.3 ENSP00000251020.4

Frequencies

GnomAD3 genomes
AF:
0.0658
AC:
9726
AN:
147732
Hom.:
382
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0537
Gnomad AMI
AF:
0.154
Gnomad AMR
AF:
0.0377
Gnomad ASJ
AF:
0.0377
Gnomad EAS
AF:
0.0214
Gnomad SAS
AF:
0.0225
Gnomad FIN
AF:
0.0879
Gnomad MID
AF:
0.0229
Gnomad NFE
AF:
0.0841
Gnomad OTH
AF:
0.0414
GnomAD2 exomes
AF:
0.0679
AC:
12552
AN:
184844
AF XY:
0.0685
show subpopulations
Gnomad AFR exome
AF:
0.0622
Gnomad AMR exome
AF:
0.0375
Gnomad ASJ exome
AF:
0.0459
Gnomad EAS exome
AF:
0.0297
Gnomad FIN exome
AF:
0.0885
Gnomad NFE exome
AF:
0.0897
Gnomad OTH exome
AF:
0.0763
GnomAD4 exome
AF:
0.0981
AC:
107547
AN:
1095922
Hom.:
3144
Cov.:
42
AF XY:
0.0972
AC XY:
52536
AN XY:
540650
show subpopulations
African (AFR)
AF:
0.0671
AC:
1679
AN:
25030
American (AMR)
AF:
0.0454
AC:
1328
AN:
29244
Ashkenazi Jewish (ASJ)
AF:
0.0523
AC:
917
AN:
17530
East Asian (EAS)
AF:
0.0362
AC:
924
AN:
25494
South Asian (SAS)
AF:
0.0395
AC:
2259
AN:
57216
European-Finnish (FIN)
AF:
0.116
AC:
4420
AN:
37986
Middle Eastern (MID)
AF:
0.0383
AC:
158
AN:
4122
European-Non Finnish (NFE)
AF:
0.107
AC:
91913
AN:
855662
Other (OTH)
AF:
0.0905
AC:
3949
AN:
43638
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
5915
11830
17745
23660
29575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3382
6764
10146
13528
16910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0658
AC:
9728
AN:
147836
Hom.:
382
Cov.:
31
AF XY:
0.0646
AC XY:
4670
AN XY:
72256
show subpopulations
African (AFR)
AF:
0.0536
AC:
2186
AN:
40754
American (AMR)
AF:
0.0376
AC:
559
AN:
14854
Ashkenazi Jewish (ASJ)
AF:
0.0377
AC:
127
AN:
3372
East Asian (EAS)
AF:
0.0215
AC:
110
AN:
5128
South Asian (SAS)
AF:
0.0226
AC:
107
AN:
4742
European-Finnish (FIN)
AF:
0.0879
AC:
897
AN:
10204
Middle Eastern (MID)
AF:
0.0211
AC:
6
AN:
284
European-Non Finnish (NFE)
AF:
0.0841
AC:
5513
AN:
65548
Other (OTH)
AF:
0.0410
AC:
84
AN:
2048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.419
Heterozygous variant carriers
0
458
916
1374
1832
2290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0762
Hom.:
147
Bravo
AF:
0.0618
ESP6500AA
AF:
0.0461
AC:
201
ESP6500EA
AF:
0.0630
AC:
540
ExAC
AF:
0.0592
AC:
6302

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Townes syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Townes-Brocks syndrome 1 Benign:1
May 28, 2020
Genetics and Molecular Pathology, SA Pathology
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.73
DANN
Benign
0.21
DEOGEN2
Benign
0.23
.;T;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.32
T;T;T
MetaRNN
Benign
0.0023
T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.34
.;N;.
PhyloP100
-0.090
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.43
N;N;N
REVEL
Benign
0.033
Sift
Benign
0.46
T;T;T
Sift4G
Benign
0.45
T;T;.
Polyphen
0.034
.;B;.
Vest4
0.090
MPC
0.18
ClinPred
0.0027
T
GERP RS
-0.37
Varity_R
0.041
gMVP
0.12
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13336129; hg19: chr16-51175658; COSMIC: COSV51752690; COSMIC: COSV51752690; API